|
1
|
Qiu MZ and Xu RH: The progress of targeted
therapy in advanced gastric cancer. Biomark Res. 1:322013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wong H and Yau T: Targeted therapy in the
management of advanced gastric cancer: Are we making progress in
the era of personalized medicine. Oncologist. 17:346–358. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Murray GI, Duncan ME, Arbuckle E, Melvin
WT and Fothergill JE: Matrix metalloproteinases and their
inhibitors in gastric cancer. Gut. 43:791–797. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pereira AL, Veras SS, Silveira EJ, Seabra
FR, Pinto LP, Souza LB and Freitas RA: The role of matrix
extracellular proteins and metalloproteinases in head and neck
carcinomas: An updated review. Braz J Otorhinolaryngol. 71:81–86.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang X, Wang Y, Yamamoto G and Tachikawa
T: Expression of matrix metalloproteinases MMP-2, MMP-9 and their
tissue inhibitors TIMP-1 and TIMP-2 in the epithelium and stroma of
salivary gland pleomorphic adenomas. Histopathology. 55:250–260.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Desgrouas C, Taudon N, Bun SS, Baghdikian
B, Bory S, Parzy D and Ollivier E: Ethnobotany, phytochemistry and
pharmacology of Stephania rotunda Lour. J Ethnopharmacol.
154:537–563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fang LH, Zhang YH and Ku BS: Fangchinoline
inhibited the antinociceptive effect of morphine in mice.
Phytomedicine. 12:183–188. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim HS, Zhang YH, Oh KW and Ahn HY:
Vasodilating and hypotensive effects of fangchinoline and
tetrandrine on the rat aorta and the stroke-prone spontaneously
hypertensive rat. J Ethnopharmacol. 58:117–123. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin TY, Lu CW, Tien LT, Chuang SH, Wang
YR, Chang WH and Wang SJ: Fangchinoline inhibits glutamate release
from rat cerebral cortex nerve terminals (synaptosomes). Neurochem
Int. 54:506–512. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xing Z, Zhang Y, Zhang X, Yang Y, Ma Y and
Pang D: Fangchinoline induces G1 arrest in breast cancer cells
through cell-cycle regulation. Phytother Res. 27:1790–1794. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang CD, Huang JG, Gao X, Li Y, Zhou SY,
Yan X, Zou A, Chang JL, Wang YS, Yang GX and He GY: Fangchinoline
induced G1/S arrest by modulating expression of p27, PCNA, and
cyclin D in human prostate carcinoma cancer PC3 cells and tumor
xenograft. Biosci Biotechnol Biochem. 74:488–493. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang N, Pan W, Zhu M, Zhang M, Hao X,
Liang G and Feng Y: Fangchinoline induces autophagic cell death via
p53/sestrin2/AMPK signalling in human hepatocellular carcinoma
cells. Br J Pharmacol. 164:731–742. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo B, Su J, Zhang T, Wang K and Li X:
Fangchinoline as a kinase inhibitor targets FAK and suppresses
FAK-mediated signaling pathway in A549. J Drug Target. 23:266–274.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Magee PJ, Allsopp P, Samaletdin A and
Rowland IR: Daidzein, R-(+)equol and S-(−)equol inhibit the
invasion of MDA-MB-231 breast cancer cells potentially via the
down-regulation of matrix metalloproteinase-2. Eur J Nutr.
53:345–350. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen PN, Hsieh YS, Chiou HL and Chu SC:
Silibinin inhibits cell invasion through inactivation of both
PI3K-Akt and MAPK signaling pathways. Chem Biol Interact.
156:141–150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sampieri CL, León-Córdoba K and
Remes-Troche JM: Matrix metalloproteinases and their tissue
inhibitors in gastric cancer as molecular markers. J Cancer Res
Ther. 9:356–363. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sier CF, Kubben FJ, Ganesh S, Heerding MM,
Griffioen G, Hanemaaijer R, van Krieken JH, Lamers CB and Verspaget
HW: Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are
related to the overall survival of patients with gastric carcinoma.
Br J Cancer. 74:413–417. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Beliën AT, Paganetti PA and Schwab ME:
Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive
migration of glioma cells in central nervous system white matter. J
Cell Biol. 144:373–384. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deryugina EI, Luo GX, Reisfeld RA, Bourdon
MA and Strongin A: Tumor cell invasion through matrigel is
regulated by activated matrix metalloproteinase-2. Anticancer Res.
17:3201–3210. 1997.PubMed/NCBI
|
|
20
|
Chen HJ, Lin CM, Lee CY, Shih NC, Amagaya
S, Lin YC and Yang JS: Phenethyl isothiocyanate suppresses
EGF-stimulated SAS human oral squamous carcinoma cell invasion by
targeting EGF receptor signaling. Int J Oncol. 43:629–637.
2013.PubMed/NCBI
|
|
21
|
Lu KH, Yang HW, Su CW, Lue KH, Yang SF and
Hsieh YS: Phyllanthus urinaria suppresses human osteosarcoma cell
invasion and migration by transcriptionally inhibiting u-PA via ERK
and Akt signaling pathways. Food Chem Toxicol. 52:193–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang SF, Chen MK, Hsieh YS, Yang JS,
Zavras AI, Hsieh YH, Su SC, Kao TY, Chen PN and Chu SC:
Antimetastatic effects of Terminalia catappa L. on oral cancer via
a down-regulation of metastasis-associated proteases. Food Chem
Toxicol. 48:1052–1058. 2010. View Article : Google Scholar : PubMed/NCBI
|
